| Status | Study |
| Active, not recruiting |
Study Name: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition: Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Date: 2014-01-28 Interventions: Drug: MEK inhibitor MEK162 Giv |
| Active, not recruiting |
Study Name: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant Condition: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Megakaryob Date: 2014-01-15 Interventions: Drug: Lenalidomide Given PO |
| Completed |
Study Name: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Date: 2013-06-03 Interventions: Drug: Cytarabine Given IV |
| Active, not recruiting |
Study Name: Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leu Date: 2013-04-19 Interventions: Drug: azacitidine Given IV or |
| Active, not recruiting |
Study Name: Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leu Date: 2013-03-25 Interventions: Drug: Sirolimus Given PO |
| Recruiting |
Study Name: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leu Date: 2013-02-26 Interventions: Drug: mitoxantrone hydrochloride |
| Completed |
Study Name: Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia Condition: Childhood Acute Monoblastic Leukemia (M5a) Childhood Date: 2012-07-13 Interventions: Other: laboratory biomarker analysis Correlative studies |
| Active, not recruiting |
Study Name: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2012-06-21 Interventions: Drug: Cytarabine Given IV |
| Active, not recruiting |
Study Name: Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Megakaryob Date: 2011-08-19 Interventions: Drug: Bortezomib Given SC |
| Completed |
Study Name: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Date: 2011-05-24 Interventions: Drug: Tipifarnib Given PO |